Log In
Print
BCIQ
Print
Print this Print this
 

PP-001

  Manage Alerts
Collapse Summary General Information
Company Panoptes Pharma GmbH
DescriptionSmall molecule inhibitor of dihydroorotate dehydrogenase (DHODH)
Molecular Target Dihydroorotate dehydrogenase (DHODH)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationUveitis
Indication DetailsTreat chronic uveitis
Regulatory Designation

Partner

4SC AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today